CL2011000767A1 - Emulsion de aceite en agua que contiene (i) fase hidrofobica interna en cantidades desde 1 a 40 %, (ii)una fase hidrofilica externa desde 60 a 99 %, (iii) al menos un surfactante polimerico en cantidades desde 0,50 a 2,50 y (iv) al menos unprincipio activo insoluble en agua en cantidades desde 0,01 al 25 % por peso. - Google Patents

Emulsion de aceite en agua que contiene (i) fase hidrofobica interna en cantidades desde 1 a 40 %, (ii)una fase hidrofilica externa desde 60 a 99 %, (iii) al menos un surfactante polimerico en cantidades desde 0,50 a 2,50 y (iv) al menos unprincipio activo insoluble en agua en cantidades desde 0,01 al 25 % por peso.

Info

Publication number
CL2011000767A1
CL2011000767A1 CL2011000767A CL2011000767A CL2011000767A1 CL 2011000767 A1 CL2011000767 A1 CL 2011000767A1 CL 2011000767 A CL2011000767 A CL 2011000767A CL 2011000767 A CL2011000767 A CL 2011000767A CL 2011000767 A1 CL2011000767 A1 CL 2011000767A1
Authority
CL
Chile
Prior art keywords
amounts
water
phase
iii
oil
Prior art date
Application number
CL2011000767A
Other languages
English (en)
Spanish (es)
Inventor
Emanuela Mura
Federico Mailland
Daniela Ceriani
Original Assignee
Polichem Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40340663&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2011000767(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Polichem Sa filed Critical Polichem Sa
Publication of CL2011000767A1 publication Critical patent/CL2011000767A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/345—Nitrofurans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Colloid Chemistry (AREA)
CL2011000767A 2008-10-08 2011-04-06 Emulsion de aceite en agua que contiene (i) fase hidrofobica interna en cantidades desde 1 a 40 %, (ii)una fase hidrofilica externa desde 60 a 99 %, (iii) al menos un surfactante polimerico en cantidades desde 0,50 a 2,50 y (iv) al menos unprincipio activo insoluble en agua en cantidades desde 0,01 al 25 % por peso. CL2011000767A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08166058A EP2174650A1 (en) 2008-10-08 2008-10-08 Modified release emulsions for application to skin or vaginal mucosa

Publications (1)

Publication Number Publication Date
CL2011000767A1 true CL2011000767A1 (es) 2011-06-17

Family

ID=40340663

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2011000767A CL2011000767A1 (es) 2008-10-08 2011-04-06 Emulsion de aceite en agua que contiene (i) fase hidrofobica interna en cantidades desde 1 a 40 %, (ii)una fase hidrofilica externa desde 60 a 99 %, (iii) al menos un surfactante polimerico en cantidades desde 0,50 a 2,50 y (iv) al menos unprincipio activo insoluble en agua en cantidades desde 0,01 al 25 % por peso.

Country Status (19)

Country Link
US (1) US20110195944A1 (https=)
EP (2) EP2174650A1 (https=)
JP (1) JP2012505171A (https=)
KR (1) KR20110067115A (https=)
CN (1) CN102170862A (https=)
AR (1) AR073801A1 (https=)
AU (1) AU2009301275A1 (https=)
BR (1) BRPI0920565A2 (https=)
CA (1) CA2737255A1 (https=)
CL (1) CL2011000767A1 (https=)
CO (1) CO6361898A2 (https=)
EA (1) EA201170555A1 (https=)
IL (1) IL211681A0 (https=)
MA (1) MA32687B1 (https=)
MX (1) MX2011003696A (https=)
NZ (1) NZ591919A (https=)
PE (1) PE20110449A1 (https=)
WO (1) WO2010040632A1 (https=)
ZA (1) ZA201101818B (https=)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10286056B2 (en) * 2011-01-27 2019-05-14 Glaxosmithkline Biologicals S.A. Adjuvant nanoemulsions with crystallisation inhibitors
US9056137B2 (en) 2011-04-01 2015-06-16 University Of Florida Research Foundation, Incorporated Thermo-sensitive, mucoadhesive or dermoadhesive, and penetration-enhancing formulations for topical delivery of therapeutics
DE102011076869A1 (de) * 2011-06-01 2012-12-06 Beiersdorf Ag Emulsionszubereitungen mit verbesserten rheologischen Eigenschaften
BR112014012444B1 (pt) 2011-11-23 2021-12-14 Therapeuticsmd, Inc Composição farmacêutica compreendendo estradiol solubilizado, progesterona e um agente de solubilização, bem como usos desta para tratar um sintoma relacionado à menopausa em uma mulher
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
CN110075310A (zh) 2011-12-20 2019-08-02 维奥姆治疗有限公司 用于治疗真菌感染的局部油组合物
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
WO2014167554A2 (en) * 2013-04-12 2014-10-16 Vyome Biosciences Pvt. Ltd. Composition and formulation of antimicrobial agents, processes thereof and methods for treating microbial infections
CA2942345C (en) * 2014-03-12 2020-12-01 Warner Chilcott Company, Llc Low-dose estradiol cream
RU2016143081A (ru) 2014-05-22 2018-06-26 Терапьютиксмд, Инк. Натуральные комбинированные гормонозаместительные составы и терапии
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
US9931349B2 (en) 2016-04-01 2018-04-03 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
CA3040422A1 (en) * 2016-10-13 2018-04-19 Catalent U.K. Swindon Zydis Limited Lyophilized pharmaceutical compositions for vaginal delivery
KR20200019735A (ko) * 2017-06-22 2020-02-24 비라말 리미티드 약물 전달을 위한 조성물 및 그의 사용 방법
WO2019213473A1 (en) 2018-05-04 2019-11-07 The Procter & Gamble Company Compositions and methods for treating vaginal dryness
BR112021007877A2 (pt) 2018-10-26 2021-08-03 Viramal Limited composição em gel mucoadesiva
EP3659583B1 (en) 2018-11-30 2023-06-07 Viramal Limited A method of preparing a gelling agent, the gelling agent obtained thereby, and the use of said gelling agent

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE414511T1 (de) * 2000-12-05 2008-12-15 Los Angeles Childrens Hospital Pharmazeutische zusammensetzungen von fenretinid mit erhöhter bioverfügbarkeit und verfahren zu deren verwendung
US20030228340A1 (en) * 2002-04-04 2003-12-11 Gans Eugene H. Methods for treating rosacea with pyridones
US20060018937A1 (en) * 2002-10-25 2006-01-26 Foamix Ltd. Steroid kit and foamable composition and uses thereof
US20060233721A1 (en) * 2002-10-25 2006-10-19 Foamix Ltd. Foam containing unique oil globules
US20040087564A1 (en) * 2002-10-31 2004-05-06 Wright D. Craig Delivery composition and method
CA2611577A1 (en) * 2005-06-07 2007-09-07 Foamix Ltd. Antibiotic kit and composition and uses thereof
US20070071705A1 (en) * 2005-09-29 2007-03-29 De Oliveira Monica A M Topical anti-microbial compositions
US20080075745A1 (en) * 2006-09-21 2008-03-27 Glenmark Pharmaceuticals Limited Topical pharmaceutical compositions containing ciclopirox or a pharmaceutically acceptable salt thereof

Also Published As

Publication number Publication date
EP2331065A1 (en) 2011-06-15
PE20110449A1 (es) 2011-07-07
JP2012505171A (ja) 2012-03-01
AR073801A1 (es) 2010-12-01
MX2011003696A (es) 2011-06-20
US20110195944A1 (en) 2011-08-11
CA2737255A1 (en) 2010-04-15
AU2009301275A2 (en) 2011-04-28
CN102170862A (zh) 2011-08-31
NZ591919A (en) 2012-09-28
ZA201101818B (en) 2012-05-30
WO2010040632A1 (en) 2010-04-15
BRPI0920565A2 (pt) 2015-12-29
MA32687B1 (fr) 2011-10-02
IL211681A0 (en) 2011-06-30
KR20110067115A (ko) 2011-06-21
EA201170555A1 (ru) 2011-12-30
AU2009301275A1 (en) 2010-04-15
EP2174650A1 (en) 2010-04-14
CO6361898A2 (es) 2012-01-20

Similar Documents

Publication Publication Date Title
CL2011000767A1 (es) Emulsion de aceite en agua que contiene (i) fase hidrofobica interna en cantidades desde 1 a 40 %, (ii)una fase hidrofilica externa desde 60 a 99 %, (iii) al menos un surfactante polimerico en cantidades desde 0,50 a 2,50 y (iv) al menos unprincipio activo insoluble en agua en cantidades desde 0,01 al 25 % por peso.
MX2010010782A (es) Composiciones para regadera y tina.
ECSP088670A (es) Sistema de administracion de plaguicidas
MX2010002340A (es) Formulacion en emulsion estable que dificulta la interaccion a traves de la interfase agua-aceite.
UY29005A1 (es) Composiciones plaguicidas líquidas.-
AR092403A1 (es) Nanoparticula polimerica de finasterida y minoxidil, proceso de preparacion, suspension acuosa conteniendo la misma, composicion farmaceutica, y su uso
CR20140539A (es) Preparación que contiene por lo menos un fungicida conazólico
BRPI0907480A2 (pt) emulsões de óleo em água estabilizadas incluindo ingredientes agricolamente ativos
CL2013000437A1 (es) Forma de dosificacion farmaceutica con resistencia a la rotura de al menos 500 n, que contiene un ingrediente activo, 5 al 70 % en peso de una sal inorganica, al menos 30% en peso de un oxido de polialquileno, en donde el ingrediente activo esta integrado en una matriz de liberacion controlada que comprende la sal inorganica y el oxido de polialquileno.
DOP2010000318A (es) Formulaciones mejoradas para ingredientes farmaceuticos activos de permeabilidad deficiente
AR071561A1 (es) Formulaciones de emulsion de pickering
CO6251306A2 (es) Fabricacion procesamiento empaque y administracion de una bebida utilizando agua activada electroquimicamente
CL2010001619A1 (es) Composiciones que comprenden una silicona de formula definida y un componente adicional; metodo para formular dichas composiciones; y emulsiones acuosas y no acuosas que comprenden a dichas composiciones (div. sol. n° 656-07).
PE20151519A1 (es) Composicion de liposoma
MX2009004767A (es) Preparacion liquida que comprende un complejo de pimobendan y ciclodextrina.
AR087838A1 (es) Composiciones parasiticidas que comprenden un agente activo de isoxazolina, sus metodos y usos
MX2020005942A (es) Delgada pelicula oral con alta carga de agente activo.
AR071568A1 (es) Composicion de suspension pesticida acuosa
GT200800247A (es) Papel impregnado con principios activos insecticidas
AR116485A2 (es) Una mayonesa libre de edta
BRPI0800177A (pt) composição agroquìmica lìquida contendo composto hidrofóbico agroquimicamente ativo
CL2013003128A1 (es) Composición herbicida que comprende a) una fase de aceite discontinua que comprende un principio activo y un solvente orgánico inmiscible en agua, b) una fase acuosa continua que comprende una sal de glifosato y agua, y c) al menos dos tensioactivos emulsionantes de copolímero en bloque; método de preparación.
AR086395A1 (es) Envase para el tratamiento de patologias
CL2015001565A1 (es) Composición, en forma de suspensión acuosa, que comprende al menos un compuesto de triazina, un principio activo adicional y uno o más tensioactivos; kit que comprende la composición; método de preparación y uso de un tesioactivo.
BRPI0910110A2 (pt) Emulsões óleo-em-água estabilizadas incluindo ingredientes agricolamente ativos